Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Acta Neuropathol. 131, 587-604 (2016)
Deposition of the nuclear DNA/RNA-binding protein Fused in sarcoma (FUS) in cytosolic inclusions is a common hallmark of some cases of frontotemporal lobar degeneration (FTLD-FUS) and amyotrophic lateral sclerosis (ALS-FUS). Whether both diseases also share common pathological mechanisms is currently unclear. Based on our previous finding that FUS deposits are hypomethylated in FTLD-FUS but not in ALS-FUS, we have now investigated whether genetic or pharmacological inactivation of Protein arginine methyltransferase 1 (PRMT1) activity results in unmethylated FUS or in alternatively methylated forms of FUS. To do so, we generated FUS-specific monoclonal antibodies that specifically recognize unmethylated arginine (UMA), monomethylated arginine (MMA) or asymmetrically dimethylated arginine (ADMA). Loss of PRMT1 indeed not only results in an increase of UMA FUS and a decrease of ADMA FUS, but also in a significant increase of MMA FUS. Compared to ADMA FUS, UMA and MMA FUS exhibit much higher binding affinities to Transportin-1, the nuclear import receptor of FUS, as measured by pull-down assays and isothermal titration calorimetry. Moreover, we show that MMA FUS occurs exclusively in FTLD-FUS, but not in ALS-FUS. Our findings therefore provide additional evidence that FTLD-FUS and ALS-FUS are caused by distinct disease mechanisms although both share FUS deposits as a common denominator.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
11.360
2.334
48
54
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Amyotrophic Lateral Sclerosis (als) ; Arginine Methylation ; Frontotemporal Lobar Degeneration (ftld) ; Fused In Sarcoma (fus) ; Neurodegeneration ; Protein Arginine Methyltransferase 1 (prmt1) ; Transportin-1; Amyotrophic-lateral-sclerosis; Frontotemporal Lobar Degeneration; Protein Arginine Methyltransferase; Sarcoma Ews Protein; Nuclear Import; In-vivo; Methylation Sites; Mass-spectrometry; Linked Mutations; Fet Proteins
Sprache
englisch
Veröffentlichungsjahr
2016
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0001-6322
e-ISSN
1432-0533
Zeitschrift
Acta Neuropathologica
Quellenangaben
Band: 131,
Heft: 4,
Seiten: 587-604
Verlag
Springer
Verlagsort
New York
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30505 - New Technologies for Biomedical Discoveries
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er)
Immune Response and Infection
Enabling and Novel Technologies
Enabling and Novel Technologies
PSP-Element(e)
G-501793-001
G-552800-001
G-552800-001
WOS ID
WOS:000372297500007
Scopus ID
84961231197
PubMed ID
26895297
Erfassungsdatum
2016-02-21